⏰ ONLY 2 DAYS LEFT! "BURST ignites the untapped potential of resident doctors and med students... it's a launchpad for a brilliant medical career" - Mr Benjamin Lamb, Consultant Urologist 🗓️ Apply by Feb 28th: redcap.slms.ucl.ac.uk/surveys/?s=3JX… #BURST10 #UroSoMe

Great to see the #STAMPEDE trial shortlisted for the National Institute for Health and Care Research Impact Prize 2025! 🏆 nihr.ac.uk/about-us/our-i… MRC Clinical Trials Unit at UCL Nick James also on @Prof-Nick-James.bsky.social Max Parmar AttardLab GU Cancer Research group The Christie NHS Manchester Cancer Research Centre

🚀 BURST @ EAU 2025 – less than 2 weeks to go! ✨ BURST turns 10 at EAU 2025 👉 Join us for a special session on the future of collaborative research. 📅 Sat 22nd March | ⏰ 13:00 - 15:00 | 📍 Room A6.1, Madrid 📢 See the full programme! #EAU25 #BURST10 #UroSoMe

Fantastic news #NIHRImpactPrize recognising the impact of the #STAMPEDE trial for patients with advanced prostate cancer! Nick James also on @Prof-Nick-James.bsky.social MRC Clinical Trials Unit at UCL AttardLab GU Cancer Research group Manchester Cancer Research Centre The Christie NHS

Our Treasurer Alexander Ng representing #BURST at the ESRU Board Meeting at #EAU25 — sharing updates and opportunities for collaboration! Join us tomorrow for the full BURST session: 📅 Saturday 22 March ⏰ 13:00–15:00 📍 Room A6.1 See you there! #UroSoMe

What if we screened smarter, not just more? In BARCODE1, men with high polygenic risk (top 10%) had MRI + biopsy— 40% had prostate cancer. Over half needed treatment. Most would’ve been missed by PSA alone. Genetics is rewriting the rules. #ProstateCancer #PrecisionMedicine

Congratulations to Toby Page and his team ⁦Newcastle Urology⁩ for an outstanding analysis of >150,000 procedures for benign prostate enlargement in England over 10 years looking at the roll out of new procedures and real life outcomes bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…

We feel this fills an essential gap in the evidence. Our meta-analysis of >4k patients undergoing Colour Doppler Sonography shows 95% sensitivity and 98% specificity for testicular torsion 👇

Great to see this Cochrane-style systematic review published by Cameron Alexander & Keiran Clement, both were my students at University of Aberdeen along with several other colleagues I’ve had the pleasure of working with including Veeru Kasi Nikita Bhatt Sinan Khadhouri BURST Urology Eur Urol Focus

A big evidence-based step forward in progress for the diagnosis and management of torsion. Well done BURST Urology for this fantastic work

BURST Urology Eur Urol Focus European Urology Veeru Kasi Ben Challacombe Nikita Bhatt Hannah Warren Cameron Alexander Sinan Khadhouri BAUS In the USA ultrasound testes is always done by the time urology evaluates the patients. It's really a no brainer that it will add to the decision making regarding exploration. Congrats on the MA

Join a supportive + ambitious team in a role which combines urological cancer care at world-renowned The Christie NHS cancer hospital with academic/higher degree opportunities of Manchester Cancer Research Centre 👇 Reach out for more info if interested!

🚨 #BURSTatBAUS #BAUS25 🚨 ‼️ Mark your calendars - 3 unmissable sessions await! 😎 📰 Mon: FAKE NEWS! Challenging the Evidence 🎤 Tue: TUF × BURST - The Research X Factor 🩸 Wed: Haematuria - You've got it all wrong See you there! 👇🧵 BURST Urology BAUS #UroSoMe

Our cancer research building, the Paterson, picked up two awards at the recent Property Week and Construction News Life Sciences & Research Clusters Awards. We won in the ‘Best New Building’ and ‘Social Value & Community Impact’ categories. 🏆

Online: Metformin for patients with metastatic #prostatecancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol silke gillessen, Nick James also on @Prof-Nick-James.bsky.social, Ashwin Sachdeva, and colleagues thelancet.com/journals/lanon…

Could adding metformin to standard treatment help reduce side effects in men with advanced #ProstateCancer? A team led by Prof Noel Clarke Division of Cancer Sciences, The Christie NHS, and Salford Urology share exciting new findings in The Lancet Oncology. Grab a ☕ and read: doi.org/10.1016/S1470-…

Delighted to have been awarded the The Royal College of Surgeons of England research fellowship to fund the remainder of my PhD studies into the utility of radiomic biomarkers in hormone sensitive prostate cancer, following in the footsteps of Omar El-Taji. GU Cancer Research group Ashwin Sachdeva Manchester Cancer Research Centre.